EUVIMEDEUVIMED entdecken
Open Access

The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5

Man Zhao iD, Dalin Zhang iD, Haowen Jiang iD, Nishanth Kuganesan, Suchitra Natarajan iD, Leighton Pu, Kaushik N Thakkar iD, Hongjuan Zhao, Quynh Thu Le iD, Amato J Giaccia iD, James D Brooks iD, Donna M Peehl und 2 weitere

Science Advances · 20.06.2025 · 11 (25)

DOI: 10.1126/sciadv.adv2417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 20.06.2025. Verfasst von Man Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Glutamine, Carcinoma, Renal Cell, Amino Acid Transport System ASC. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutamine reprogramming plays a crucial role in the growth and survival of clear cell renal cell carcinoma (ccRCC), although the mechanisms governing its regulation are still not fully understood. We demonstrate that the RNA demethylase fat mass and obesity-associated gene (FTO) drives glutamine reprogramming to support ccRCC growth and survival. Genetic and pharmacologic inhibition of FTO in ccRCC cells impaired glutamine-derived reductive carboxylation, depleted pyrimidines, and increased reactive oxygen species. This led to increased DNA damage and reduced survival, which could be rescued by pyrimidine nucleobases or the antioxidant N -acetylcysteine. Mechanistically, FTO demethylates the glutamine transporter solute carrier family 1 member 5 (SLC1A5) messenger RNA to promote its expression. Restoration of SLC1A5 expression in FTO-knockdown cells rescued metabolic and survival defects. FTO inhibition reduced ccRCC tumor xenograft and PDX growth under the renal capsule. Our findings indicate that FTO is an epitranscriptomic regulator of ccRCC glutamine reprogramming and highlight the therapeutic potential of targeting FTO for the treatment of ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alpha-Ketoglutarate-Dependent Dioxygenase FTOGlutamineCarcinoma, Renal CellAmino Acid Transport System ASCMinor Histocompatibility AntigensKidney NeoplasmsHumansAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationReactive Oxygen Species

Substanzen

Alpha-Ketoglutarate-Dependent Dioxygenase FTOGlutamineSLC1A5 protein, humanAmino Acid Transport System ASCMinor Histocompatibility AntigensFTO protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA.
  • Department of Urology, Stanford University, Stanford, CA 94305, USA.
  • Department of Oncology, University of Oxford, Oxford, UK.
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94158, USA.
  • Department of Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA.

ORCID-Profile: Man Zhao, Dalin Zhang, Haowen Jiang, Suchitra Natarajan, Kaushik N Thakkar, Quynh Thu Le, Amato J Giaccia, James D Brooks, Jiangbin Ye, Erinn B Rankin

Förderung

  • NCI NIH HHS

Zitieren

APA

Zhao, M., Zhang, D., Jiang, H., Kuganesan, N., Natarajan, S., Pu, L., Thakkar, K. N., Zhao, H., Le, Q. T., Giaccia, A. J., Brooks, J. D., Peehl, D. M., Ye, J., & Rankin, E. B. (2025). The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5. Science Advances, 11(25). https://doi.org/10.1126/sciadv.adv2417

Vancouver

Zhao M, Zhang D, Jiang H, Kuganesan N, Natarajan S, Pu L, et al. The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5. Science Advances. 2025;11(25). doi:10.1126/sciadv.adv2417

BibTeX
@article{Zhao2025,
  author = {Zhao, Man and Zhang, Dalin and Jiang, Haowen and Kuganesan, Nishanth and Natarajan, Suchitra and Pu, Leighton and Thakkar, Kaushik N and Zhao, Hongjuan and Le, Quynh Thu and Giaccia, Amato J and Brooks, James D and Peehl, Donna M and Ye, Jiangbin and Rankin, Erinn B},
  title = {The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {25},
  doi = {10.1126/sciadv.adv2417}
}
Kostenlos starten →